Expression of stretch-activated potassium channels in human myometrium

Proceedings of the Western Pharmacology Society

Volumn 48, Issue , 2005, Pages 44-48

  Tichenor, Jennifer N ^a   Hansen, Eric T ^a   Buxton, Iain L O ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL; MESSENGER RNA; POTASSIUM CHANNEL; RIBOSOME RNA;

CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LABOR; MYOMETRIUM; NUCLEOTIDE SEQUENCE; PREGNANCY; PREMATURE LABOR; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

DNA PRIMERS; FEMALE; HUMANS; MECHANORECEPTORS; MYOMETRIUM; PHYSICAL STIMULATION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, RIBOSOMAL, 18S;

EID: 30144444698     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Meis, P.J., Klebanoff, M., Thorn, E., Dombrowski, M.P., Sibai, B., Moawad, A.H., Spong, C.Y., Hauth, U.C., Miodovnik, M., Varner, M.W., Leveno, K.J., Caritis, S.N., Iams, J.D., Wapner, R.J., Conway, D., O'Sullivan, M.J., Carpenter, M., Mercer, B., Ramin, S.M., Thorp, J.M. and Peaceman, A.M. (2003) New England Journal of Medicine 348: 2379-2385
2. ACOG. Int.J.Gynaecol.Obstet. 82: 127-135, 2003.
3. Hall, M.H., Danielian, P. and Lamont, R.F. (1997) The Importance of Preterm Birth. In: Preterm Labor (Eds. Elder MJ, Romero R, and Lament RF), pp. 1-28. Churchill Livingstone, London.
4. Higby, K. and Suiter, C.R. (1999) Drug Saf. 21: 35-56.
5. Kuenzli, K.A., Bradley, M.E. and Buxton, I.L. (1996) Br. J. Pharmacol. 119: 737-743.
6. Kuenzli, K.A., Buxton, I.L. and Bradley, M.E. (1998) Br. J. Pharmacol. 124: 63-68.
7. Bradley, K.K., Buxton, I.L., Barber, J.E., McGaw, T. and Bradley, M.E. (1998) Am. J. Physiol. 275: C1668-C1673.
8. Tichenor, S., Malmquist, N.A. and Buxton, I.L. (2001) Proc. West. Pharmacol. Soc. 44: 53-56.
9. Buxton, I.L., Kaiser, R.A., Malmquist, N.A. and Tichenor, S. (2001) Br. J. Pharmacol. 134: 206-214.
10. Mazzone, J.N., Kaiser, R.A. and Buxton, I.L. (2002) Proc. West. Pharmacol. Soc. 45: 184-186.
11. Mazzone, J. and Buxton, I.L. (2003) Proc. West. Pharmacol. Soc. 46: 74-77.
12. Park, K.J., Baker, S.A., Cho, S.Y., Sanders, K.M. and Koh, S.D. (2005) Br. J. Pharmacol. 144: 1126-1137.
13. Koh, S.D., Monaghan, K., Sergeant, G.P., Ro, S., Walker, R.L., Sanders, K.M. and Horowitz, B. (2001) J. Biol. Chem. 276: 44338-44346.
14. Medhurst, A.D., Rennie, G., Chapman, C.G., Meadows, H., Duckworth, M.D., Kelsell, R.E., Gloger, I.I. and Pangalos, M.N. (2001) Brain Res. Mol. Brain Res. 86: 101-114.
15. Talley, E.M., Solorzano, G., Lei, Q., Kim, D. and Bayliss, D.A. (2001) J. Neurosci. 21: 7491-7505.
16. Patel, A.J., Lazdunski, M. and Honore, E. (2001) Curr. Opin. Cell. Biol. 13: 422-428.
17. Kim, D. (2003) Trends Pharmacol. Sci. 24: 648-654.
18. Lesage, F., Terrenoire, C., Romey, G. and Lazdunski, M. (2000) J. Biol. Chem. 275: 28398-28405.
19. Patel, A.J., Honore, E., Lesage, F., Fink, M., Romey, G. and Lazdunski, M. (1999) Nat. Neurosci. 2: 422-426.
20. Gruss, M., Bushell, T.J., Bright, D.P., Lieb, W.R., Mathie, A. and Franks, N.P. (2004) Mol. Pharmacol. 65: 443-452.
21. Harinath, S. and Sikdar, S.K. (2004) Neuropharmacology 46: 750-760.
22. Heurteaux, C., Guy, N., Laigle, C., Blondeau, N., Duprat, F., Mazzuca, M., Lang-Lazdunski, L., Widmann, C., Zanzouri, M., Romey, G. and Lazdunski, M. (2004) EMBO. J. 23: 2684-2695.
23. Patel, A.J. and Honore, E. (2001) Trends Neurosci. 24: 339-346.
24. Bai, X., Bugg, G.J., Greenwood, S.L., Glazier, J.D., Sibley, C.P., Baker, P.N., Taggart, M.J. and Fyfe, G.K. (2005) Reproduction 129: 525-530.
25. Tichenor, S.D., Malmquist, N.A. and Buxton, I.L. (2003) Cell Signal. 15: 763-772.
26. Koh, S.D. and Sanders, K.M. (2001) J. Physiol. 533: 155-163.
27. Elovitz, M.A. and Mrinalini, C. (2004) Trends Endocrinol. Metab 15: 479-487.
28. Kroetz, D.L. and Xu, F. (2005) Ann. Rev. Pharmacol. Toxicol. 45: 413-438.
29. Buxton, I.L. (2004) Mol. Pharmacol. 65: 1051-1059.